Intro

The chapter explores the efficacy of new weight loss drugs that mimic entero-pancreatic hormones, offering a significant advancement in managing obesity. These medications are approved for patients with specific body mass index levels and medical complications, with prescribing decisions based on various factors including diet, obesity-related issues, self-care abilities, and collaborative care decisions.